Basic Information
| LncRNA/CircRNA Name | LINC01207 |
| Synonyms | NA |
| Region | GRCh38_4:164754131-164803795 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR, RNAi, Western blot, RIP, ChIP etc. |
| Sample | NSCLC tissues, cell lines (A549) |
| Expression Pattern | up-regulated |
| Function Description | LINC01207 was significantly up-regulated in LAD tissues compared with paired non-tumor tissues, while there was no significant differences between LSCC tissues and adjacent non-tumor tissues. The expression level of LINC01207 was associated with TNM stage of LAD patients, and higher LINC01207 level indicated advanced TNM stage and shorter survival. |
| Pubmed ID | 26693067 |
| Year | 2015 |
| Title | The long noncoding RNA LINC01207 promotes proliferation of lung adenocarcinoma. |
External Links
| Links for LINC01207 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |